Study On Uorouracil-Chitosan Nanoparticle Preparation and Its Antitumor Effect
Study On Uorouracil-Chitosan Nanoparticle Preparation and Its Antitumor Effect
Study On Uorouracil-Chitosan Nanoparticle Preparation and Its Antitumor Effect
ORIGINAL ARTICLE
a
Pharmacy Department, Nanyang Medical College, Nanyang 473061, China
b
Public Teaching Department, Nanyang Medical College, Nanyang 473061, China
KEYWORDS Abstract To successfully prepare fluorouracil–chitosan nanoparticles, and further analyze its
Fluorouracil; anti-tumor activity mechanism, this paper makes a comprehensive study of existing preparation
Chitosan; prescription and makes a detailed analysis of fluorouracil–chitosan in vitro release and pharmaco-
Nanoparticles; dynamic behavior of animals. Two-step synthesis method is adopted to prepare 5-FU–CS–mPEG
Preparation method; prodrugs, and infrared, 1H NMR and differential thermal analysis are adopted to analyze
Antitumor effect characterization synthetic products of prepared drugs. To ensure clinical efficacy of prepared drugs,
UV spectrophotometry is adopted for determination of drug loading capacity of prepared drugs,
transmission electron microscopy is adopted to observe the appearance, dynamic dialysis method
is used to observe in vitro drug release of prepared drugs and fitting of various release models is
done. Anti-tumor effect is studied via level of animal pharmacodynamics. After the end of the
experiment, tumor inhibition rate, spleen index and thymus index of drugs are calculated. Experi-
mental results show that the prepared drugs are qualified in terms of regular shape, dispersion, drug
content, etc. Animal pharmacodynamics experiments have shown that concentration level of drug
loading capacity of prepared drugs has a direct impact on anti-tumor rate. The higher the concen-
tration, the higher the anti-tumor rate. Results of pathological tissue sections of mice show that the
prepared drugs cause varying degrees of damage to receptor cells, resulting in cell necrosis or
apoptosis problem. It can thus be concluded that ion gel method is an effective method to prepare
drug-loading nanoparticles, with prepared nanoparticles evenly distributed in regular shape which
demonstrate good slow-release characteristics in receptor vitro and vivo. At the same time, after
completion of drug preparation, relatively strong anti-tumor activity can be generated for the
receptor, so this mode of preparation enjoys broad prospects for development.
Ó 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.jsps.2016.04.008
1319-0164 Ó 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Study on nanoparticle preparation and its effect 251
cancer, stomach cancer, esophageal cancer and colorectal can- system; its shape is mostly solid colloidal particles with diam-
cer and other gastrointestinal cancers have a high incidence eter of 10–1000 nm (Li et al., 2012a,b). Nanoparticles have sig-
(Chao and Zhang, 2012). Currently, chemotherapy is one of nificant medicinal property transport advantages, so
the primary means for treatment of cancer, but its treatment preparation of nanoparticles has always been the focus of
effect is subject to drug side effects and drug resistance. In research questions. With constant progress and development
recent years, with the blend of molecular biology, molecular of chemical preparation level, preparation mode of nanoparti-
pharmacology, polymer materials, thermal chemistry and cles demonstrates significant diversification characteristics. In
other subjects, the researchers have developed controlled this paper, preparation effect of fluorouracil–chitosan
release preparations and targeting preparation which can be nanoparticles with ion gel method is deeply analyzed, and its
intelligently controlled according to tumor site characteristics inhibitory effect for cancer tumors is explored.
(Wang et al., 2010; Li et al., 2012a,b; He et al., 2011). Chitosan
(shown as Fig. 1) (CS), the product of deacetylation of chitin, 2. Materials and methods
is the only alkaline polysaccharide in nature. With broad range
of sources, good biodegradability, biocompatibility and low 2.1. Fluorouracil–chitosan preparation
toxicity, it is widely used in such aspects as pharmaceutical,
textile, environmental monitoring and tissue repair. But inter-
Chitosan (molecular weight 5.0 104), 5-fluorouracil, poly-
molecular and intramolecular hydrogen-bond interaction
ethylene glycol monomethyl ether 5000 (mPEG), 1-ethyl-3-(3
reduces its solubility, only partially soluble in acid, such as
-dimethylaminopropylamine) carbodiimide salt, silicate
acetic acid, hydrochloric acid, methane sulfonic acid. In order
(EDC s_ HCl), N-hydroxysuccinimide (NHS), succinic anhy-
to make excellent the properties of chitosan that are benefit for
dride, 4-dimethylaminopyridine (DMAP), N,N-dimethylf-
more cancer patients, chitosan must be modified. 5-Fluo-
ormamide (DMF), anhydrous ether, chloroacetic acid, methyl
rouracil (shown as Fig. 2) (5-Fu) is an anticancer drug of
orange/phenolphthalein, dialysis bags, and deuterated reagent.
DNA synthesis cycle. As its cells enjoy relatively strong
Acid/ alkaline buret, 8LGJ-18A freeze-drying machine,
destruction characteristics, it is widely used in the treatment
WQF-410 Fourier transform spectrometer, 500 MHz fully dig-
of a variety of solid tumors such as colorectal cancer, stomach
ital superconducting NMR spectrometer, UV-1700 UV spec-
cancer, breast cancer in clinics. However, metabolic rate of the
trophotometer, DF-101S heat collection constant
drug is relatively fast, which easily leads to problems such as
temperature magnetic stirrer, constant temperature magnetic
gastrointestinal reactions and poor selectivity, so these drugs
stirrer, differential scanning calorimeter.
are not very widespread in practice. To enhance anti-cancer
Determination of degree of deacetylation of chitosan: (1)
effect and reduce toxicity, over the years, people have done a
Determine degree of deacetylation of chitosan; (2) demarcate
lot of chemical modification work on 5-FU, to effectively
acid or alkaline solution with primary standard substance
reduce side effects of these drugs (Xu et al., 2014). Nanoparti-
anhydrous Na2CO3; and (3) Calculate the degree of deacetyla-
cles (NP) is ultra fine particle decentralized administration sys-
tion: formula is as follows:
tem formed by aggregate, poly charge of natural or synthetic
polymer materials, which belongs to colloid administration ð–NH2 Þ% ¼ f½ðC1 V1 C2 V2 Þ 0:016=Gg100%
DD ¼ ½ð–NH2 Þ%=9:94%100%
wherein C1 represents concentration of HCl, V1 represents
HCl volume needed, G represents mass of chitosan, C2 repre-
sents concentration of NaOH standard solution, and V2 repre-
sents volume of NaOH.
Preparation of polyethylene glycol monomethyl ether chi-
tosan, with synthetic method is shown in Fig. 3 below (Yan
et al., 2011a,b).
Structural characterization of polyethylene glycol mono-
methyl ether chitosan of 5-fluorouridine conjugate: (1) Weigh
1–2 mg sample after drying treatment with infrared spec-
Figure 1 Chemical structure of chitosan. trophotometry (FT-IR), after mixed compression with KBr,
measure on infrared instrument, with scan range at
4000–400 cm1; (2) nuclear magnetic resonance spectroscopy
(1H NMR), measure 1H NMR of substance with AVANCE
III 500 MHz NMR instrument, measuring solvent of 5-FUA
is DMSO-d6, measuring solvent of mPEG is D2O, and mea-
suring solvent of other substances is mixed solution of deuter-
ated water and deuterated hydrochloric acid (D2O/DCl) (Yan
et al., 2012). Degree of substitution of mPEG on chitosan is
calculated with integration of characteristic peaks in 1H
NMR. (3) Differential thermal analysis method employs Per-
kin ElmerDSC4000 for determination: Weigh 5 mg substance
for die determination, nitrogen flow rate: 20 ml/min, measur-
Figure 2 Chemical structure of 5-fluorouracil. ing range: 20–300 °C.
252 G. Chen, R. Gong
there is significant difference (P < 0.05), and tumor inhibition He, L.Q., Zhu, L., Yang, Y., 2008. Preparation and in vitro properties
rate of high dose group is comparable with positive control of folate-conjugated 5-fluorouracil chitosan nanoparticles. J.
group (5-FU) (P > 0.05); histopathologic slide shows that Guangdong Pharm. Univ. 6, 565–568.
cells of administration group are with different degrees of Li, Q., Zhuang, C.J., Cheng, M.R., 2012a. Experimental study on
galactosyl chitosan/5-fluorouracil nanoparticles’ inhibition of mice
necrosis and apoptosis.
orthotopic liver cancer transplantation model. Prog. Mod. Biomed.
35, 6819–6823.
4. Discussion and conclusion Li, Q., Zhuang, C.J., Cheng, M.R., 2012b. Experimental study of mice
liver cancer inhibition with galactosyl chitosan/5-fluorouracil
Drug-loaded nanoparticles prepared by ion gel method enjoy nanoparticles. Mod. J. Integr. Tradit. Chin. Western Med. 34,
3790–3793.
significant advantages, mainly uniform particle size, regular
Wang, J., Lin, Y.W., Wang, M.N., 2010. Preparation and properties of
shape and strong sustained release characteristics. The results
5-fluorouracil magnetic nanoparticles. Chin. J. Tissue Eng. Res. 47,
of animal experiments show that drug concentration exerts 8809–8813.
clear impact on anti-tumor effect. Therefore, during the course Xu, H.Z., Cheng, M.R., Wang, Y., 2014. Glycyrrhetinic acid modified
of drug treatment, disease parting of patients should be fully chitosan 5-fluorouracil’s inhibitory effect on liver cancer. Mod. J.
identified to develop reasonable therapeutic regimens. Integr. Tradit. Chin. Western Med. 21 (2281–2285), 2301.
Yan, C.Y., Gu, J.W., Huang, Z., 2011a. Preparation of lyophilized 5-
References fluorouracil-N-succinyl chitosan nanoparticles. Heilongjiang Med.
Pharm. 34, 19–20.
Yan, C.Y., Gu, J.W., Wang, X., 2011b. Discussion of in vitro release
Chao, Y.Y., Zhang, H., 2012. Sustained-release fluorouracil prepara-
mechanism of 5-fluorouracil-N-succinyl chitosan nanoparticles.
tion and biological safety after implantation. Chin. J. Tissue Eng.
Heilongjiang Med. Pharm. 34, 102–102.
Res. 21, 3959–3966.
Yan, C.Y., Gu, J.W., Cheng, Y., 2012. Impact of molecular parameter
He, B., Cheng, M.R., Wan, T., 2011. Preparation of galactosyl
on physicochemical properties of 5-fluorouracil-N-succinyl chi-
chitosan 5-fluorouracil nanoparticles and experimental study on its
tosan nanoparticles. Heilongjiang Med. Pharm. 35, 28–29.
inhibition of mice colon cancer. Chin. J. Clin. Med. 6, 738–741.